Exposure to antibiotics and risk of latent autoimmune diabetes in adults and type 2 diabetes: results from a Swedish case–control study (ESTRID) and the Norwegian HUNT study
We found no evidence that exposure to broad-spectrum antibiotics up to 10 years prior to diagnosis increases the risk of LADA. There was some indication of increased LADA risk with exposure to narrow-spectrum antibiotics, which warrants further investigation.
Authors
- Marios Rossides (ORCID: https://orcid.org/0000-0002-9769-324X)
- Emma Ahlqvist (ORCID: https://orcid.org/0000-0002-6513-2384)
- Daniela Di Giuseppe (ORCID: https://orcid.org/0000-0003-3817-8288)
- Johan Askling (ORCID: https://orcid.org/0000-0003-0433-0616)
- Sofia Carlsson (ORCID: https://orcid.org/0000-0002-9497-2331)
- Bjørn Olav Åsvold (ORCID: https://orcid.org/0000-0003-3837-2101)
- Lars S. Alfredsson (ORCID: https://orcid.org/0000-0003-1688-6697)
- Elin Pettersen Sørgjerd (ORCID: https://orcid.org/0000-0002-5995-2386)
- Jessica Edstorp (ORCID: https://orcid.org/0000-0002-6009-8738)
- Valdemar Grill (ORCID: https://orcid.org/0000-0001-6959-022X)
Institutions
- Karolinska University Hospital (SE)
- University of Helsinki (FI)
- Lund University (SE)
- Norwegian University of Science and Technology (NO)
- Helsinki University Hospital (FI)
- Karolinska Institutet (SE)
- St Olav's University Hospital (NO)
- Institute for Molecular Medicine Finland (FI)
- Centre for Palaeogenetics (SE)
- Folkhälsans Forskningscentrum (FI)
Publication Details
- Journal
- Diabetologia
- Published
- 2024-10-28
- DOI
- https://doi.org/10.1007/s00125-024-06302-5
- Primary Topic
- Diabetes and associated disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Stiftelsen för Strategisk Forskning
- Crafoordska Stiftelsen
- Lunds Universitet
- Karolinska Institutet
- Novo Nordisk
- Vetenskapsrådet
- Lund University Medical Faculty Foundation
- Direktör Albert Påhlssons Stiftelse
- Forskningsrådet om Hälsa, Arbetsliv och Välfärd
- Diabetesfonden
- Novo Nordisk Fonden